|
FY2014
12 months to Sep 30, 2014
|
FY2013
12 months to Sep 30, 2013
|
FY2012
12 months to Sep 30, 2012
|
FY2011
12 months to Sep 30, 2011
|
FY2010
12 months to Sep 30, 2010
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net income | |||||
| Consolidated net loss | |||||
| Adjustments to reconcile net loss to net cash provided by operating activities: | |||||
| Amortization of intangible assets | |||||
| Depreciation and amortization of property and equipment | |||||
| Accretion of discount and issuance costs on notes | |||||
| Provision for (recovery of) doubtful accounts | |||||
| Share-based compensation | |||||
| Revaluation of contingent consideration | |||||
| Deferred Income Taxes | |||||
| Excess tax benefits from share-based compensation | |||||
| Gain (loss) from equity investments | |||||
| Payments of contingent consideration | |||||
| Changes in operating assets and liabilities, net of effects from acquisitions: | |||||
| Accounts receivable, net | |||||
| Deferred costs and other assets | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Deferred revenues | |||||
| Net cash provided by operating activities | |||||
| Investing activities: | |||||
| Purchases of investments | |||||
| Maturities of investments | |||||
| Increase (decrease) in customer funding liabilities, net of changes in restricted cash | |||||
| Investment in and loans to unconsolidated affiliates | |||||
| Proceeds from sale of cost method Investments | |||||
| Capital expenditures | |||||
| Payments for acquisitions, net of cash acquired | |||||
| Payments of contingent consideration related to acquisition of Etap | |||||
| Net cash used in investing activities | |||||
| Financing activities: | |||||
| Equity issuance costs | |||||
| Proceeds from bank loans | |||||
| Proceeds from borrowings on convertible senior notes, net | |||||
| Proceeds from warrant | |||||
| Payment for convertible senior note hedges | |||||
| Investments in consolidated joint venture by noncontrolling interest | |||||
| Payments on repurchase of common stock | |||||
| Net proceeds from share-based equity award activity | |||||
| Proceeds from employee stock purchase plan activity | |||||
| Minimum tax withholding on restricted stock awards | |||||
| Excess tax benefits from share-based compensation | |||||
| Repayments on capital leases | |||||
| Payments of contingent consideration | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of foreign currency exchange rate changes on cash and cash equivalents | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Supplemental cash flow information: | |||||
| Cash paid for interest | |||||
| Income tax payments, net | |||||
| Common stock issued in connection with acquisition | |||||
Loading...